Trends in the proportion (%) of antimicrobial-resistant Escherichia coli[the proportion of antimicrobial resistance in humans]
![Trends in the proportion (%) of antimicrobial-resistant Escherichia coli[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0101Escherichia-coliã®èæ§çã®æ¨ç§»-G.png)
A statistical information site that deepens
the understanding of AMR (drug resistance) and one health
A statistical information site that deepens
the understanding of AMR (drug resistance) and one health
![Trends in the proportion (%) of IPM and MEPM-resistant Escherichia coli and parenteral Carbapenems consumption calculated from the sales[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0151Escherichia-coliã®IPMã»MEPMèæ§çã®æ¨ç§»ã¨è²©å£²é-G.png)
![Trends in the proportion (%) of LVFX-resistant Escherichia coli and oral Fluoroquinolones consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0152Escherichia-coliã®LVFXèæ§çã®æ¨ç§»ã¨è²©å£²é-G.png)
![Trends in the proportion (%) of LVFX-resistant Escherichia coli and parenteral Fluoroquinolones consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0153Escherichia-coliã®LVFXèæ§çã®æ¨ç§»ã¨è²©å£²é-G.png)
![Trends in the proportion (%) of ABPC-resistant Escherichia coli[the proportion of antimicrobial resistance in humans and animals]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0131Escherichia-coliã®ABPCèæ§çã®æ¨ç§»-G.png)
![Trends in the proportion (%) of CEZ-resistant Escherichia coli[the proportion of antimicrobial resistance in humans and animals]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0132Escherichia-coliã®CEZèæ§çã®æ¨ç§»-G.png)
![Trends in the proportion (%) of CTX-resistant Escherichia coli[the proportion of antimicrobial resistance in humans and animals]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0133Escherichia-coliã®CTXèæ§çã®æ¨ç§»-G.png)
![Trends in the proportion (%) of Fluoroquinolones-resistant Escherichia coli[the proportion of antimicrobial resistance in humans and animals]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0134Escherichia-coliã®Fluoroquinolonesèæ§çã®æ¨ç§»-G.png)